美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Medicus Pharma Ltd.

2.09

0.0000

盤後：2.02-0.0700-3.35%18:09 EDT

成交量：19.80萬

成交額：41.08萬

市值：3,723.60萬

市盈率：-1.53

高：2.11

開：2.09

低：2.02

收：2.09

52周最高：8.94

52周最低：1.79

股本：1,781.63萬

流通股本：974.00萬

量比：0.56

換手率：2.03%

股息：- -

股息率：- -

每股收益(TTM):-1.3692

每股收益(LYR):-1.1597

淨資產收益率：-352.45%

總資產收益率：-102.95%

市淨率：11.46

市盈率(LYR):-1.80

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Medicus Pharma Ltd.

交易所：

NASDAQ

成立時間：

2015

員工人數：

- -

公司地址：

One First Canadian Place,100 King Street West,Suite 3400,Toronto,Ontario,Canada

官網：

http://www.medicuspharma.com

郵編：

M5X 1A4

電話：

- -

傳真：

- -

簡介：

Medicus Pharma Ltd.於2008年4月30日根據加拿大安大略省法律成立。他們是一家生物技術和生命科學公司，專註於加快新型和顛覆性治療資產的臨床開發項目。目前，他們正在開發一種產品SkinJectTM，用於治療基底細胞癌。通過其全資子公司SkinJect, Inc.，他們專註於開發其許可的藥物器械組合產品，使用新型可溶解微針陣列治療非羊毛瘤皮膚癌。他們的聯合候選產品是根據新藥研究申請向美國食品和藥物管理局（“FDA”）提交的阿黴素尖端裝載D-MNA，受腫瘤科藥物評估和註冊中心（CDER）的監管。

董事

名稱

職位

Raza Bokhari

Executive Chairman and Chief Executive Officer

Barry Fishman

Independent Director

Larry Kaiser

Independent Director

Ajay Raju

Director

Cathy McMorris Rodgers

Director

Patrick J. Mahaffy

Director

股東

名稱

職位

Raza Bokhari

Executive Chairman and Chief Executive Officer

Andrew Smith

Chief Operating Officer

James Quinlan

Chief Financial Officer

Carolyn Bonner

President

Edward Brennan

Chief Scientific Officer & Head of Research and development Program

Faisal Mehmud

Chief Medical Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MDCX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDCX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","market":"US","secType":"STK","nameCN":"Medicus Pharma Ltd.","latestPrice":2.09,"timestamp":1757448000000,"preClose":2.09,"halted":0,"volume":197959,"hourTrading":{"tag":"盘后","latestPrice":2.02,"preClose":2.09,"latestTime":"18:09 EDT","volume":104,"amount":213.8600048,"timestamp":1757455789738},"delay":0,"floatShares":9740000,"shares":17816266,"eps":-1.369182,"marketStatus":"盤後交易","change":0,"latestTime":"09-09 18:43:33 EDT","open":2.09,"high":2.11,"low":2.02,"amount":410790.4221192,"amplitude":0.043062,"askPrice":2.18,"askSize":100,"bidPrice":2.02,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-1.369182,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1757462400000},"marketStatusCode":4,"adr":0,"listingDate":1731560400000,"exchange":"NASDAQ","adjPreClose":2.09,"preHourTrading":{"tag":"盘前","latestPrice":2.09,"preClose":2.09,"latestTime":"09:28 EDT","volume":3165,"amount":6602.960994,"timestamp":1757424517732},"postHourTrading":{"tag":"盘后","latestPrice":2.02,"preClose":2.09,"latestTime":"18:09 EDT","volume":104,"amount":213.8600048,"timestamp":1757455789738},"volumeRatio":0.555491},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","floatShares":9740000,"roa":"-102.95%","roe":"-352.45%","lyrEps":-1.159715,"volumeRatio":0.555491,"shares":17816266,"dividePrice":0,"high":2.11,"amplitude":0.043062,"preClose":2.09,"low":2.02,"week52Low":1.7901,"pbRate":"11.46","week52High":8.94,"institutionHeld":0,"latestPrice":2.09,"committee":-0.666667,"eps":-1.369182,"divideRate":0,"volume":197959,"delay":0,"ttmEps":-1.369182,"open":2.09,"prevYearClose":2.43,"prevWeekClose":1.88,"prevMonthClose":1.94,"prevQuarterClose":2.99,"fiveDayClose":2.08,"twentyDayClose":1.97,"sixtyDayClose":2.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1744689600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MDCX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MDCX","date":"2025-09-08","current":-1.959459,"percent":0.888889,"low":-2.313829,"twenty":-2.186673,"median":-2.100165,"eighty":-2.009488,"high":-1.907346,"avg":-2.103292,"sd":0.118818,"marketCap":33494580},"quantilePoints":[{"date":"2025-08-29","current":-2.084531,"twenty":-2.272139,"median":-2.126221,"eighty":-2.109545,"marketCap":35632532},{"date":"2025-09-05","current":-1.907346,"twenty":-2.205434,"median":-2.115799,"eighty":-2.053263,"marketCap":32603766},{"date":"2025-09-08","current":-1.959459,"twenty":-2.186673,"median":-2.100165,"eighty":-2.009488,"marketCap":33494580}],"updateTime":1757457813276},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":301013012,"yearFounded":2015,"address":"One First Canadian Place,100 King Street West,Suite 3400,Toronto,Ontario,Canada","zipCode":"M5X 1A4"},"stockCompanyDetail":{"websiteUrl":"http://www.medicuspharma.com","stockEarnings":[{"period":"1week","weight":-0.0309},{"period":"1month","weight":-0.1931},{"period":"3month","weight":-0.3188},{"period":"6month","weight":-0.3836},{"period":"1year","weight":-0.3935},{"period":"ytd","weight":-0.2263}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.0229},{"period":"3month","weight":0.0803},{"period":"6month","weight":0.1238},{"period":"1year","weight":0.1776},{"period":"ytd","weight":0.1044}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Medicus Pharma Ltd.於2008年4月30日根據加拿大安大略省法律成立。他們是一家生物技術和生命科學公司，專註於加快新型和顛覆性治療資產的臨床開發項目。目前，他們正在開發一種產品SkinJectTM，用於治療基底細胞癌。通過其全資子公司SkinJect, Inc.，他們專註於開發其許可的藥物器械組合產品，使用新型可溶解微針陣列治療非羊毛瘤皮膚癌。他們的聯合候選產品是根據新藥研究申請向美國食品和藥物管理局（“FDA”）提交的阿黴素尖端裝載D-MNA，受腫瘤科藥物評估和註冊中心（CDER）的監管。","exchange":"NASDAQ","name":"Medicus Pharma Ltd.","nameEN":"Medicus Pharma Ltd."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":{"directors":[{"name":"Raza Bokhari","position":"Executive Chairman and Chief Executive Officer"},{"name":"Barry Fishman","position":"Independent Director"},{"name":"Larry Kaiser","position":"Independent Director"},{"name":"Ajay Raju","position":"Director"},{"name":"Cathy McMorris Rodgers","position":"Director"},{"name":"Patrick J. Mahaffy","position":"Director"}],"executives":[{"name":"Raza Bokhari","position":"Executive Chairman and Chief Executive Officer"},{"name":"Andrew Smith","position":"Chief Operating Officer"},{"name":"James Quinlan","position":"Chief Financial Officer"},{"name":"Carolyn Bonner","position":"President"},{"name":"Edward Brennan","position":"Chief Scientific Officer & Head of Research and development Program"},{"name":"Faisal Mehmud","position":"Chief Medical Officer"}]}}}